The Chinese American Biopharmaceutical Society (CABS) is a non-profit organization for professionals in the biopharmaceutical industry. CABS is headquartered in San Francisco Bay Area, California. About 70% of our members have PhD degree relating to life sciences. A considerable proportion of the members are holding senior research and management positions in American and multi-national life sciences corporations. Many of our members are experts and leaders, innovative entrepreneurs, lawyers and venture capitalists or investors in the life sciences sector. CABS is the largest and most active Chinese biopharmaceutical association in Northern America.
The Chinese Biopharmaceutical Association (CBA-USA) is one of the largest Chinese American professional associations in the US (www.cba-usa.org). Founded in 1995, CBA is an independent, non-political, not-for-profit professional organization led by its elected board of directors, board of advisors and executive committees.
CBA’s primary mission is to bridge biopharmaceutics between US and China. Headquartered in Maryland, CBA currently has more than 3000 registered individual members, and more than 60 institutional members. Most of the CBA members are from the local biopharmaceutical companies, universities, research institutions, and government agencies. More than 80 percent of the CBA members have doctoral degrees. In addition to members from the US, CBA also has members residing in China, Europe, Canada, Australia, Singapore, and Japan.
APBN serves as a knowledge exchange platform (print and online) to provide latest news and noteworthy information in biotechnology, healthcare, biomedical and pharmaceutical industry in Asia Pacific. Established in 1997, APBN is the first and only monthly magazine focused on biotechnology, healthcare, pharmaceutical and life science developments in China and other Asia Pacific countries. The main motivation of APBN is to bring biotechnology news in a comprehensive and concise manner to, but not limited to, clinicians, research scientists, students, and other industry professionals and experts.
Since 2004, Asia Research News has been helping Asia’s universities and research institutions promote new research findings and academic expertise to a wider international audience, including the media. Our services include specialist writing and targeted media distribution. Our news portal, www.researchsea.com, helps connect Asian researchers with the media and the public. We also publish the annual magazine, Asia Research News magazine, which highlights innovative and significant breakthroughs from Asia.
Bentham Science Publishers is rendering a vital service in the quality publication that publishes over 100 peer-reviewed print and online scientific, technical and medical journals. These titles are indexed in recognized indexing agencies, such as Science Citation Index®, Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE etc. Some of the high impact titles which enjoy a wide reach and distribution are Current Gene Therapy (Impact Factor 4.906), Current Alzheimer Research (Impact Factor 3.796), Current Medicinal Chemistry (Impact Factor 3.715), and other popular titles.
Bentham has an extensive library of eBooks in the areas of science, technology, medicine, social sciences and humanities. Bentham eBooks publishes monographs, handbooks, conference proceedings, textbooks, review volumes, biographies and autobiographies.
- FREE online journals and information: www.benthamscience.com
- Subscribe, Consortia, discounted global licenses and trials: email@example.com
- To know more about our publications please visit here
Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.
BioProcess International is a magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process.
Established since 1998, Bio-Equip is a leading website for lab equipments, reagents, consumables and bio services. Our users come from different fields like life science, medical research, pharmaceutical, biotechnology, modern agriculture, food safety and environment monitoring. Bio-Equip offer users a complete product directory which involves 158 product ranges among lab equipments, reagents, consumables, lab animals, bio services, cell lines, bio software and books.Serving users through two websites, www.bio-equip.com (Chinese) and www.bio-equip.cn (English), we own over 20,000 registered suppliers and more than 500,000 pieces of product and technical service information with details of product description, price, sample downloading, technical articles and videos.
BioSpectrum Asia is the most influential source of information for life sciences industry and is uniquely positioned as a specialized B2B information platform in Asia Pacific region. The magazine provides comprehensive coverage and useful insights in the areas of pharmaceuticals, biotechnology, medical devices, research & development and policies
BiotechEast provides information and services related to Taiwan’s growing life science industries. Our services cover a wide scope, including marketing and business intelligence, investment sourcing, and partner identification and vetting. Founded in 2003, our mission is connecting Taiwan and overseas companies within this industry space, for the advancement of medical technology and the benefit of patients everywhere.
The Cell Culture Dish and the Downstream Column are online publications designed to provide a community for scientists and others involved in biotechnology. The goal is to share expertise and best practices as well as discuss topics of interest to the community. Articles cover areas important to the application, development and regulatory approval of mammalian cell culture processes and products. This includes biomanufacturing, vaccines, cell culture and purification, regenerative medicine, cord blood stem cells, cellular therapy, cell-based assays, diagnostic antibodies, life science research and related applications.
Clarivate Analytics is the global leader in providing trusted insights and analytics to accelerate the pace of innovation. Building on a heritage going back more than a century and a half, we have built some of the most trusted brands across the innovation lifecycle, including Web of Science, Cortellis, Derwent, CompuMark, MarkMonitor and Techstreet. Today, Clarivate Analytics is a new and independent company on a bold entrepreneurial mission to help our clients radically reduce the time from new ideas to life-changing innovations. For more information, please visit clarivate.com.
SOURCE newswire provides comprehensive coverage of breaking news for the life sciences industry in China. Daily updates allow timely tracking of key company developments, deal-making, and regulatory trends, with the primary focus on the pharmaceutical industry.
- Daily News Briefs: receive 3-4 original articles each day
- Email alerts on topics of interest by keyword.
- Access a fully searchable archive of 20,940 original articles
- Filter news by story type: company news; product/R&D trends; pricing and reimbursement decisions; and general policy developments
- Ability to save and share favorite news items.
Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN’s unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, and commercialization.
KONGPOSH Publications is one of the leading Pharma publishers of India. Our publications are – The Pharma Review® is a bi-monthly article based journal. Covering news, views and articles on various fields of pharmacy including Clinical Trials, Biotechnology, Review/Research papers, Herbal Medicine and much more. Contributions received from Eminent pharma personalities from India as well as other countries which helps us to have a varied and rich content matter. Participation and distribution in over 20 Expos & Conferences worldwide each year. It is widely read by decision makers, middle management and the academia. The journal is Abstracted & Indexed in International Pharmaceutical Abstract & Chemical Abstract – USA, Index Copernicus – Poland & Ulrich’s Journal Database– USA for the quality of its content. Also available on our website and E-book format.
For regular complimentary link of the journal write to us on firstname.lastname@example.org.
Lingmed Ltd was founded in 2013 in Hong Kong, currently we have offices in Shanghai and Beijing. Lingmed promotes three leading intelligence databases for healthcare professionals in China to make better decisions. Lingmed’s core products are healthcare intelligence databases; it covers global innovative assets & China market intelligence. Lingmed’s Products and Services have been recognized by Fortune 500 multinational pharma and device companies as well as Chinese local big pharmacos. In addition, we together with our partners in Europe provide partnering services to bridge European and Chinese pharmaceuticals with biotech companies, including valuation and market monitoring reports.
In the realm of Pharmacy, where innovation is rapid, Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space. Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers. Pharmaceutical-Tech.com covers in-depth trends that shape industry dynamics and metamorphose global economics. With services like search engine optimization, global magazine, social media marketing, product video showcase, e-mail marketing, e-newsletter sponsorship, banner advertising, event marketing and micro-website within our platform, www.pharmaceutical-tech.com has created a recognition that spans over a global audience, thereby revolutionizing how businesses transact.
Pharma China (www.pharmachinaonline.com) is the most trusted English media and business intelligence service covering the Chinese pharmaceutical / biopharmaceutical industry and market.
Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most multinational pharmaceutical companies, leading CROs, investment banks and consulting firms active in China as well as relevant industry associations and government agencies.
- Pharma China Journal Edition (monthly in PDF and Print)
- Pharma China Web Edition (continuously-updated news, in-depth commentaries and online databases)
- China Pharmaceutical Guide (the most comprehensive and authoritative reference for China’s healthcare sector)
Pharma Focus Asia is a quarterly magazine from Ochre Media Pvt. Ltd. Pharma Focus Asia covers important issues and trends shaping the future of the Pharma industry across Asia and rest of the world. It is the leading Pharma title in print as well as digital versions serving the information needs of key executives from the world’s leading pharmaceutical companies.
Informa’s Pharma Intelligence is the trusted partner of the top 50 global pharmaceutical companies and the top 10 contract research organisations (CRO’s) – providing timely intelligence and insight to help them make authoritative decisions.
From drug and device discovery and development to regulatory approval, drug reimbursement to lifecycle management – we provide the global intelligence and insight to help advance our partners’ initiatives in a fast changing market.
Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.
Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.
Technology Networks scientific communities offer today’s scientists a single resource that contains unique, engaging, and entertaining content from their field of research.